The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1299
November 17, 2008
View Complete Issue         Table of Contents 2019 
Advertisements for TNF Inhibitors
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Advertisements for TNF Inhibitors
November 17, 2008 (Issue: 1299)
Some tumor necrosis factor (TNF) inhibitors are being promoted on the internet directly to the public for use in psoriasis (www.yahoo.com).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Advertisements for TNF Inhibitors
Article code: 1299a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.